These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7660447)

  • 1. Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan.
    Baraka OZ; Mahmoud BM; Ali MM; Ali MH; el Sheikh EA; Homeida MM; Mackenzie CD; Williams JF
    Trans R Soc Trop Med Hyg; 1995; 89(3):312-5. PubMed ID: 7660447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivermectin treatment of hyperreactive onchodermatitis (sowda) in Liberia.
    Darge K; Büttner DW
    Trop Med Parasitol; 1995 Dec; 46(4):206-12. PubMed ID: 8826099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community based distribution of ivermectin in eastern Sudan: acceptability and early post-treatment reactions.
    Baraka OZ; Khier MM; Ahmed KM; Ali MM; el Mardi AE; Mahmoud BM; Ali MH; Homeida MM; Williams JF
    Trans R Soc Trop Med Hyg; 1995; 89(3):316-8. PubMed ID: 7660448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human onchocerciasis and "sowda" in the Republic of Yemen].
    Richard-Lenoble D; al Qubati Y; Toe L; Pisella PJ; Gaxotte P; al Kohlani A
    Bull Acad Natl Med; 2001; 185(8):1447-59; discussion 1459-61. PubMed ID: 11974966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in severe onchocercal skin disease after a single dose of ivermectin.
    Pacqué M; Elmets C; Dukuly ZD; Muñoz B; White AT; Taylor HR; Greene BM
    Am J Med; 1991 May; 90(5):590-4. PubMed ID: 2029016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells in onchocercomas from patients with hyperreactive onchocerciasis (sowda).
    Korten S; Wildenburg G; Darge K; Büttner DW
    Acta Trop; 1998 Jun; 70(2):217-31. PubMed ID: 9698269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
    Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
    Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi.
    Burnham G
    Am J Trop Med Hyg; 1995 Mar; 52(3):270-6. PubMed ID: 7694970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivermectin in human onchocerciasis: a clinical-pathological study of skin lesions before and three days after treatment.
    Vuong PN; Traoré S; Wanji S; Diarrassouba S; Balaton A; Bain O
    Ann Parasitol Hum Comp; 1992; 67(6):194-6. PubMed ID: 1301733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of Onchocerca volvulus in Sudan.
    Mukhtar MM; Khier MM; Baraka OZ; Homeida MM
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S129-31. PubMed ID: 9861278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history.
    Ali MM; Baraka OZ; AbdelRahman SI; Sulaiman SM; Williams JF; Homeida MM; Mackenzie CD
    J Infect Dis; 2003 Feb; 187(4):714-7. PubMed ID: 12599094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
    Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
    Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Onchocerca volvulus microfilariae from skin snips before and after treatment of patients with ivermectin.
    Mössinger J; Schulz-Key H; Dietz K
    Trop Med Parasitol; 1988 Dec; 39(4):313-6. PubMed ID: 3067322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda).
    Gallin MY; Jacobi AB; Büttner DW; Schönberger O; Marti T; Erttmann KD
    J Exp Med; 1995 Jul; 182(1):41-7. PubMed ID: 7790822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
    Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
    Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
    Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
    Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ivermectin in paste and injectable formulations against microfilariae of Onchocerca cervicalis and resolution of associated dermatitis in horses.
    French DD; Klei TM; Foil CS; Miller RI; Foil LD; Chapman MR; McClure JJ
    Am J Vet Res; 1988 Sep; 49(9):1550-4. PubMed ID: 3223664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph nodes of onchocerciasis patients after treatment with ivermectin: reaction of eosinophil granulocytes and their cationic granule proteins.
    Wildenburg G; Darge K; Knab J; Tischendorf FW; Bonow I; Büttner DW
    Trop Med Parasitol; 1994 Jun; 45(2):87-96. PubMed ID: 7939167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.